top of page

Patent Portfolios Details

IPHatch Asia

HKUST 04

Pathological Condition Treatment

• HK Exclusive •

Require to set up a Hong Kong company


HKUST

US8389544


Title of Patent:

Isoquinolone compounds as subtype-selective agonists for melatonin receptors MT1 and MT2

  • Isoquinolone compounds that are capable of modulating melatonin receptors and to pharmaceutical compositions containing such compounds for treating disorders or pathological conditions associated with melatonin receptors in mammalian subjects

  • Method to treat, prevent or ameliorate a pathological condition in mammal

  • Promising therapeutic agents used to treat insomnia and circadian-related disorders such as jet lag


 

Potential Areas of Applications:
  • Medicine

  • Healthcare

  • Cure Sleep Disorders

  • Pharmaceutical


 

Proposed Schemes:

Licensing


* Schemes are subjected to the business model and are open for discussion.


IP Originated by

HKUST 03

bottom of page